 |
|
Prognostic value of serum CA-125 in patients with advanced epithelial ovarian cancer followed by complete remission after adjuvant chemotherapy
Jong Ho Moon, Hyo Jin Lee, Woo Dae Kang, Chul Hong Kim, Ho Sun Choi, Seok Mo Kim
Obstet Gynecol Sci. 2013;56(1):29-35. Published online 2013 Jan 9 DOI: https://doi.org/10.5468/OGS.2013.56.1.29
|
|
Citations to this article as recorded by
 Comparison of the short‐term efficacy and serum markers between lobaplatin/paclitaxel‐ And carboplatin/paclitaxel‐based adjuvant chemotherapy in patient with ovarian cancer
Wei Wang, Ming Liu, Boyong Ding
Journal of Clinical Pharmacy and Therapeutics.2021; 46(1): 166. CrossRef Meigs syndrome with pleural effusion as initial manifestation: A case report
Ya-Ya Hou, Li Peng, Mei Zhou
World Journal of Clinical Cases.2021; 9(21): 5972. CrossRef Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people
Hong-Yan Cheng, Lin Zeng, Xue Ye, Rui-Qiong Ma, Zhi-Jian Tang, Hong-Ling Chu, Yi-Ming Zhao, Li-Rong Zhu, Yu-Nong Gao, Xiao-Hong Chang, Heng Cui
Chinese Medical Journal.2020; 133(11): 1285. CrossRef A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
Kyung Jin Eoh, Jung Won Yoon, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
BMC Cancer.2017;[Epub] CrossRef
|